Moderna and CEPI Team Up to Advance Vaccine Candidate for Bundibugyo Ebola Strain
Moderna announced a partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) to develop a vaccine candidate targeting Bundibugyo ebolavirus, the strain implicated in the current outbreak in eastern Democratic Republic of Congo. CEPI has pledged up to $50 million for Moderna's preclinical and early clinical work and is also provid…